MDC.L Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 geg. 2023 @ 13:40):

Stats
Šios dienos apimtis	450.00
Vidutinė apimtis	3.85M
Rinkos kapitalizacija	3.69B
EPS	£0 ( 2023-11-14 )
Last Dividend	£3.00 ( 2022-08-04 )
Next Dividend	£0 ( N/A )
P/E	21.78
ATR14	£1.585 (0.32%)

Tūris Koreliacija

Ilgas: 0.13 (neutral)

Trumpas: -0.04 (neutral)

Signal:(60.912) Neutral

Mediclinic International Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Mediclinic International Koreliacija - Valiuta/Žaliavos

-0.24
( neutral )

-0.26
( neutral )

0.35
( neutral )

-0.21
( neutral )

0.21
( neutral )

0.44
( neutral )

Mediclinic International Finansinės ataskaitos

Annual	2022
Pajamos:	£3.23B
Bruto pelnas:	£505.00M (15.62 %)
EPS:	£0.210

FY	2022
Pajamos:	£3.23B
Bruto pelnas:	£505.00M (15.62 %)
EPS:	£0.210

FY	2021
Pajamos:	£3.00B
Bruto pelnas:	£426.00M (14.22 %)
EPS:	£0.0920

FY	2020
Pajamos:	£3.08B
Bruto pelnas:	£1.12B (36.43 %)
EPS:	£-0.434

Financial Reports:

No articles found.

Mediclinic International Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£3.00 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Mediclinic International Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 8.34 - good (83.45%) | Divividend Growth Potential Score: 4.50 - Potential for dividend initiation, but uncertain (10.07%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£5.24	2016-06-16
Last Dividend	£3.00	2022-08-04
Next Dividend	£0	N/A
Payout Date	2022-08-26
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	£35.14	--
Avg. Dividend % Per Year	0.19%	--
Score	2.59	--
Div. Sustainability Score	8.34
Div.Growth Potential Score	4.50
Div. Directional Score	6.42	--

Next Divdend (Est)
(2024-11-04)

£0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

2.59

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2016	£0	0.00%
2017	£0	0.00%
2018	£7.90	1.17%
2019	£7.90	2.50%
2020	£0	0.00%
2021	£0	0.00%
2022	£3.00	0.94%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SUPR.L	Dividend Knight	2023-07-13	Quarterly	8	3.25%
KEYS.L	Dividend Knight	2023-09-21	Annually	7	2.29%
CCJI.L	Dividend Knight	2023-07-06	Semi-Annually	9	2.14%
QXT.L	Ex Dividend Junior	2023-07-27	Sporadic	11	0.46%
GHH.L	Dividend Knight	2023-06-22	Annually	27	0.91%
AMC.L	Dividend Knight	2023-06-01	Insufficient data to determine frequency	2	55.57%
TPFG.L	Dividend Knight	2023-09-21	Annually	11	3.16%
MACF.L	Dividend King	2023-09-14	Semi-Annually	32	1.94%
CREI.L	Dividend Knight	2023-07-20	Quarterly	11	3.34%
RUR.L	Dividend Knight	2023-06-22	Sporadic	20	10.67%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0467	1.500	9.07	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0210	1.200	9.30	10.00	[0 - 0.3]
returnOnEquityTTM	0.0507	1.500	-0.548	-0.822	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.791	0.800	6.04	4.84	[1 - 3]
quickRatioTTM	0.656	0.800	-0.846	-0.677	[0.8 - 2.5]
cashRatioTTM	0.649	1.500	7.51	10.00	[0.2 - 2]
debtRatioTTM	0.359	-1.500	4.01	-6.02	[0 - 0.6]
interestCoverageTTM	4.52	1.000	9.44	9.44	[3 - 30]
operatingCashFlowPerShareTTM	0.751	2.00	9.75	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.509	2.00	9.75	10.00	[0 - 20]
debtEquityRatioTTM	0.833	-1.500	6.67	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.156	1.000	-0.730	-0.730	[0.2 - 0.8]
operatingProfitMarginTTM	0.0866	1.000	-0.268	-0.268	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.214	1.000	9.92	9.92	[0.2 - 2]
assetTurnoverTTM	0.449	0.800	-0.343	-0.274	[0.5 - 2]
Total Score				8.34

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	24.46	1.000	7.63	0	[1 - 100]
returnOnEquityTTM	0.0507	2.50	-0.352	-0.822	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.509	2.00	9.83	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.751	2.00	9.75	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	19.07	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.171	1.000	8.22	0	[0.1 - 0.5]
Total Score				4.50

Mediclinic International

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in the intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.